Every recall we track for IMMUNOCORE, LLC — 1 in all — plus the complaints and injury reports the public filed about them.
Immunocore recalls KIMMTRAK (tebentafusp-tebn) injection due to subpotent drug risk. Affected lots expire March 2026. No specific remedy stated in recall notice.
